http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019172602-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78cf78520cbd0bd762e19b5f48e64220 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac68176cc21324a7d25084c4dc22680 |
| publicationDate | 2019-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019172602-A |
| titleOfInvention | Blood uric acid level reducing agent and xanthine oxidase inhibitor |
| abstract | Disclosed is an agent that contains an active ingredient derived from a new natural product and is useful for the prevention and improvement of hyperuricemia and gout. A blood uric acid level-reducing agent containing a Brassica plant or an extract of Brassica plant as an active ingredient is provided. There is also provided a xanthine oxidase inhibitor containing a Brassica plant or a Brassica plant extract as an active ingredient. An example of the Brassica plant is kale. The agent of the present invention is preferably administered orally and is preferably a food composition. The agent of the present invention is useful for preventing or improving hyperuricemia or gout. [Selection] Figure 1 |
| priorityDate | 2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.